1. United Kingdom Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Treatt plc

Treatt plc

TET.L
Treatt plcGB flagLondon Stock Exchange
305.00
GBp
+0.50
- -
180.06MMarket Cap
Treatt plc
TET.L
(London Stock Exchange)

Recent

price

305.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
1.24
1.46
1.45
1.45
1.54
1.67
1.7
1.94
1.98
1.91
1.82
2.07
2.32
2.43
2.46
2.19
Revenue per Share
0.01
0.08
0.06
0.07
0.08
0.12
0.12
0.18
0.22
0.15
0.16
0.25
0.22
0.18
0.23
0.08
Basic EPS, GAAP
-0.02
0.09
-0.05
0.14
0.02
0.12
0.15
-0.06
-0.11
0.13
-0.19
-0.1
-0.23
0.26
0.25
0.1
Free Cash Flow per Basic Share
0.02
0.03
0.03
0.03
0.04
0.04
0.04
0.06
0.05
0.05
0.06
0.06
0.08
0.08
0.08
0.09
Dividend per Share
0.38
0.45
0.48
0.5
0.52
0.59
0.61
0.79
0.96
0.98
1.07
1.35
1.61
1.75
1.91
1.83
Book Value per Share
0.42
0.46
0.47
0.5
0.53
0.61
0.65
0.83
1.42
1.46
1.5
1.73
2.16
2.21
2.27
2.19
Tangible Book Value per Share
51
51
51
51
51
51
52
52
57
59
60
60
60
61
61
60
Basic Weighted Avg Shares
63
75
74
74
79
86
88
101
112
113
109
124
140
147
150
132
Sales/Revenue/Turnover
11.97
9.56
7.6
9.36
9.63
10.11
10.85
12.39
12.24
11.78
13.84
17.17
11.25
12.43
12.65
7.35
Operating Margin (%)
1
1
1
1
1
1
1
2
2
2
2
2
3
5
5
6
Depreciation Expense
1
4
3
3
4
6
6
10
12
9
10
15
13
11
14
5
Net Income, GAAP
68.42
31.65
31.15
32.24
28.23
22.97
25.85
26.75
19.8
21.31
21.08
22.78
17.7
19.21
22.67
27.69
Effective Tax Rate (%)
1.03
5.83
4.15
4.7
4.99
6.97
6.98
9.43
10.9
7.8
8.96
12.18
9.5
7.42
9.23
3.82
Profit Margin (%)
20
23
21
26
28
32
38
41
67
69
53
53
62
64
68
62
Working Capital
8
8
6
10
9
7
8
7
3
4
4
4
3
- -
- -
1
LT Debt
23
26
26
27
29
33
37
46
82
87
91
106
134
137
141
135
Total Equity
6.67
13.13
9.8
11.8
13.79
16.01
15.68
16.56
13.06
9.77
11.5
14.95
9.25
9.62
9.98
4.89
Return on Invested Capital (%)
2.39
13.92
9.44
10.6
11.94
16.77
16.35
20.46
18.83
11.39
13.19
18.18
12.37
9.65
12.17
4.42
Return on Capital (%)
3.32
20.4
12.92
13.99
15.19
20.99
19.79
26.13
25.49
15.62
16.02
20.86
14.91
10.75
12.44
4.46
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.74%
8.68%
-4.48%
Free Cash Flow
-69.28%
-35.78%
-58.95%
Net Income, GAAP
5.74%
-2.32%
-63.46%
Sales/Revenue/Turnover
4.75%
4.41%
-11.8%
Total Cash Common Dividend
10.87%
9.31%
4.53%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
150
2025
- -
- -
- -
- -
132
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.23
2025
- -
- -
- -
- -
0.08
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.08
2025
- -
- -
- -
- -
0.09
2026
- -
- -
- -
- -
- -
Similar Companies
Poet Biorefining LLC (PTBBU)
Amal Ltd (AMAL.BO)
Westlake Corporation (0LVK.L)
Sudarshan Colorants India Limited (HEUBACHIND.NS)
Ganesh Benzoplast Limited (GANESHBE.BO)
Kanto Denka Kogyo Co., Ltd. (4047.T)
Business
Treatt plc manufactures and supplies natural extracts and ingredients to the flavor, fragrance, beverage, and consumer goods industries worldwide. Founded in 1886 and headquartered in Bury St. Edmunds, United Kingdom, the company operates production and sales facilities in the UK, USA, China, and other regions, serving markets including carbonates, juices, energy drinks, RTD teas and coffees, kombucha, spirits, and low/no alcohol beverages. Its core products encompass citrus ingredients such as essential oils, blends, natural isolates, TreattZest, and TreattClear; tea solutions including Treattaromes, TrueTaste, and botanicals; coffee extracts; fruits and vegetables covering berries, tropical fruits, melons, and honeys; botanicals; herbs, spices, and florals; high-impact and aroma chemicals; health and wellness extracts; and sugar reduction technologies. Treatt generates the majority of its revenue from the USA, with additional contributions from the UK, Germany, Ireland, China, and the rest of Europe and Americas. In 2025, the company agreed to a recommended cash acquisition by Natara Global Ltd, controlled by Exponent Private Equity, at 290 pence per share valuing the business at approximately £156.6 million; the deal, approved by the board for its complementary product portfolios, enhanced geographic reach, and growth investment potential, awaits shareholder approval of at least 75% and regulatory clearances, with closure expected in 2025.